Literature DB >> 21517756

Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance.

S Trabanelli1, D Ocadlikova, C Evangelisti, S Parisi, A Curti.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) is an intracellular heme-containing enzyme that catalyzes the initial rate-limiting step in tryptophan degradation along the kynurenine pathway. Recent works have demonstrated a crucial role for IDO in the induction of immune tolerance during infections, pregnancy, transplantation, autoimmunity, and neoplasias. IDO is widely expressed in human tissues and cell subsets, including dendritic cells, where it modulates their function by increasing tolerogenic capacities. The aim of the present paper is to highlight the most recent data about IDO expression in dendritic cells and its role as a potent inducer of T regulatory cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517756     DOI: 10.2174/092986711795656054

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

1.  The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.

Authors:  Sara Trabanelli; Darina Očadlíková; Marilena Ciciarello; Valentina Salvestrini; Mariangela Lecciso; Camilla Jandus; Richard Metz; Cecilia Evangelisti; Lisa Laury-Kleintop; Pedro Romero; George C Prendergast; Antonio Curti; Roberto M Lemoli
Journal:  J Immunol       Date:  2014-01-03       Impact factor: 5.422

2.  Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo.

Authors:  Qiongxin Wang; Miao Zhang; Ye Ding; Qilong Wang; Wencheng Zhang; Ping Song; Ming-Hui Zou
Journal:  Circ Res       Date:  2013-11-26       Impact factor: 17.367

3.  Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions.

Authors:  G Chen; T Kheradmand; J Bryant; S Wang; J Tasch; J-J Wang; Z Zhang; X Luo
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

Review 4.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 5.  Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.

Authors:  Qiongxin Wang; Danxia Liu; Ping Song; Ming-Hui Zou
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

Review 6.  Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2015-05-29

7.  Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study.

Authors:  E M Apalset; C G Gjesdal; P M Ueland; Ø Midttun; A Ulvik; G E Eide; K Meyer; G S Tell
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

8.  PDGF upregulates CLEC-2 to induce T regulatory cells.

Authors:  Sudhanshu Agrawal; Sreerupa Ganguly; Pega Hajian; Jia-Ning Cao; Anshu Agrawal
Journal:  Oncotarget       Date:  2015-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.